Iksan Si
Iksan Si
Iksan Si, Jeonlabuk Do, South Korea2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Not stated | 2026-09-24 | NCT05217810 | |
| Regulatory Post-Marketing Surveillance Study for Brolucizumab | Neovascular Age-related Macular Degeneration | Recruiting | Not stated | 2025-01-14 | NCT04985487 |